Health insurance; require coverage for genetic testing for inherited mutation and evidence-based cancer imaging.
Summary
HB 1400 requires group health plans and health insurance issuers offering group or individual coverage in Mississippi to cover clinical genetic testing for inherited gene mutations when an individual has a personal or family history of cancer and the testing is recommended by a health care professional. It also requires coverage for evidence-based cancer imaging for individuals at increased risk of cancer, using the most recent NCCN clinical practice guidelines as the standard.
The bill bars insurers and group health plans from imposing cost-sharing on these covered services, meaning no deductible, copayment, coinsurance, or similar out-of-pocket expense may be charged for them. It includes a federal health savings account/high-deductible health plan safeguard so the cost-sharing prohibition is adjusted if needed to preserve HSA eligibility under federal law, except for preventive care services.
In addition to creating these new cancer-related coverage mandates, the bill brings forward Section 25-15-9 of the Mississippi Code governing the State and School Employees Health Insurance Plan. That section is largely unchanged in the bill text and continues to address the structure of the state employee health plan, advisory council procedures, retiree coverage, coordination of benefits, life insurance provisions, and related administrative rules.
The overall sentiment around the bill appears strongly favorable. The House passed HB 1400 unanimously, 117-0, indicating broad support for expanding access to cancer-related genetic testing and imaging without patient cost-sharing. No committee transcript or recorded opposition is provided in the materials.
The main points of contention are limited in the available record, but the bill’s cost implications for insurers and employers, and the interaction with high-deductible health plans and federal HSA rules, are the most likely areas of concern. The use of NCCN guidelines and the scope of who qualifies for testing and imaging could also be points of implementation discussion, though no formal objections are shown in the provided history.
Impact
HB 1400 would amend Mississippi insurance requirements by mandating coverage for specified cancer-related genetic testing and evidence-based imaging in both group and individual health insurance markets, while prohibiting cost-sharing for those services subject to federal HSA constraints. It would affect health insurers, group health plans, employers sponsoring coverage, and insured individuals who have a personal or family history of cancer or an increased cancer risk. The bill also carries forward the existing statutory framework for the State and School Employees Health Insurance Plan in Section 25-15-9, leaving that broader state employee health plan structure in place while adding the new coverage mandate to the insurance code.
Sentiment
The available voting history shows very strong support for the bill: the House passed HB 1400 unanimously, 117 yeas and 0 nays. With no committee transcript or recorded floor debate included, there is no evidence of organized opposition in the provided materials. The bill’s purpose—expanding access to cancer screening-related services and removing patient cost barriers—appears to have been broadly well received.
Contention
No explicit contention is documented in the provided record, but the most likely issues are practical and fiscal rather than ideological. Insurers and employers could be concerned about increased utilization and premium impact from mandated coverage and the elimination of cost-sharing. Another possible point of discussion is the bill’s reliance on NCCN clinical practice guidelines and the federal HSA/high-deductible plan carveout, which may require careful implementation to ensure compliance and avoid unintended effects on consumer-directed health plans.